Pembrolizumab as first-line treatment for metastatic uveal melanoma.
Rossi E, Pagliara MM, Orteschi D, Dosa T, Sammarco MG, Caputo CG, Petrone G, Rindi G, Zollino M, Blasi MA, Cassano A, Bria E, Tortora G, Schinzari G.
Rossi E, et al. Among authors: caputo cg.
Cancer Immunol Immunother. 2019 Jul;68(7):1179-1185. doi: 10.1007/s00262-019-02352-6. Epub 2019 Jun 7.
Cancer Immunol Immunother. 2019.
PMID: 31175402
Free PMC article.